The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study

被引：0

作者：

Ueno, Nobuhiro ^{[1
,2
,10
]}

Saito, Seisuke ^{[3
]}

Sato, Masahiro ^{[4
]}

Sugiyama, Yuya ^{[4
]}

Kobayashi, Yu ^{[4
]}

Murakami, Yuki ^{[4
]}

Sugimura, Kohjiro ^{[5
]}

Sasaki, Takahiro ^{[4
]}

Sakatani, Aki ^{[2
]}

Takahashi, Keitaro ^{[4
]}

Tanaka, Kazuyuki ^{[6
]}

Serikawa, Shinya ^{[7
]}

Ando, Katsuyoshi ^{[4
]}

Kashima, Shin ^{[4
]}

Muto, Momotaro ^{[8
]}

Inaba, Yuhei ^{[9
]}

Moriichi, Kentaro ^{[4
]}

Tanabe, Hiroki ^{[4
]}

Okumura, Toshikatsu ^{[4
]}

Fujiya, Mikihiro ^{[2
,4
]}

机构：

[1] Asahikawa Med Univ Hosp, Div Gen Med, Asahikawa, Hokkaido, Japan

[2] Asahikawa Med Univ, Dept Gastroenterol Sci, Asahikawa, Hokkaido, Japan

[3] Furano Hosp, Furano, Hokkaido, Japan

[4] Asahikawa Med Univ, Dept Internal Med, Div Gastroenterol, Asahikawa, Hokkaido, Japan

[5] Nakashibetsu Town Hosp, Nakashibetsu, Hokkaido, Japan

[6] Asahikawa Kosei Gen Hosp, Asahikawa, Hokkaido, Japan

[7] Nayoro City Gen Hosp, Nayoro, Hokkaido, Japan

[8] Engaru Kosei Gen Hosp, Engaru, Hokkaido, Japan

[9] Asahikawa City Hosp, Asahikawa, Hokkaido, Japan

[10] Asahikawa Med Univ Hosp, Div Gen Med, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2024年 / 28卷 / 03期

关键词：

biologics; clinical response; Crohn's disease; granulocyte and monocyte apheresis; loss of response;

D O I：

10.1111/1744-9987.14103

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: A remission induction therapy of granulocyte and monocyte adsorptive apheresis (GMA) was given to patients with Crohn's disease (CD). However, establishing an appropriate treatment strategy for GMA in patients with CD remains unclear.Methods: This study evaluated the clinical efficacy and subsequent clinical progression after GMA in patients with CD who underwent GMA in seven independent institutions in Japan from 2010 to 2023.Results: Sixteen patients were enrolled. The overall remission and response rates were 25.0% and 68.8%, respectively. All patients responding to GMA received biologics that were continuously used and 36.4% of patients remained on the same biologics 52 weeks after GMA. Notably, all patients who continued the same biologics had previously experienced a loss of response to biologics.Conclusion: GMA may exhibit effectiveness even in cases with refractory CD. Moreover, it represents a potential novel therapeutic option for refractory CD with loss of response to biologics.

引用

页码：442 / 452

页数：11

共 50 条

[41] Effect of Granulocyte and Monocyte Adsorption Apheresis With Thiopurines in Patients With Early Diagnosed Crohn's Disease
Fukuchi, Takumi
Nakase, Hiroshi
Matsuura, Minoru
Yamashita, Hiroshi
Ubukata, Satoshi
Nagatani, Yoshiaki
Koga, Hideaki
Senda, Kasane
Eguchi, Takaaki
Otsuka, Mami
Ueda, Aya
Kawaguchi, Shinpei
Ohashi, Rina
Ito, Dai
Ashida, Kiyoshi
GASTROENTEROLOGY, 2012, 142 (05) : S802 - S802
[42] Safety and efficacy of capsule endoscopy for patients with newly diagnosed Crohn's disease: A multicenter retrospective study
Kawano, Seiji
Oka, Shiro
Shiotani, Akiko
Hashimoto, Shinichi
Takahashi, Sakuma
Handa, Osamu
Takami, Taro
Inaba, Tomoki
Okada, Hiroyuki
Tanaka, Shinji
MEDICINE, 2022, 101 (50)
[43] Granulocyte and monocyte adsorptive apheresis (GMA) in patients with inflammatory bowel disease: A useful therapeutic tool not just in ulcerative colitis but also in Crohn's disease
Fernandez-Pereza, Francisco Jose
Fernandez-Morenoa, Nuria
Soria-Lopez, Estela
Rodriguez-Gonzalez, Francisco Javier
Fernandez-Galeoteb, Francisco Jose
Lifante-Olivac, Ana
Ruiz-Hernandezc, Concepcion
Escalante-Quijaitec, Elisabeth
Rivas-Ruizd, Francisco
GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (09):
[44] Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study
Yamamoto, T
Umegae, S
Kitagawa, T
Yasuda, Y
Yamada, Y
Takahashi, D
Mukumoto, M
Nishimura, N
Yasue, K
Matsumoto, K
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (07) : 783 - 792
[45] Efficacy and Safety of Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction for Intractable Ulcerative Colitis
Tanida, Satoshi
Sasoh, Shun
Otani, Takahiro
Kubota, Yoshimasa
Ban, Tesshin
Ando, Tomoaki
Nakamura, Makoto
Joh, Takashi
JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2024, 16 (05): : 256 - 263
[46] Adsorptive monocyte and granulocyte apheresis in the chronic inflammatory illness:: ulcerous colitis, Crohn's disease, rheumatoid arthritis and Behcet syndrome
Munoz, J.
Clavo, M.
Garcia, O.
Reina, D.
Vidaller, A.
Lafuente, R.
Massuet, L. I.
ISBT SCIENCE SERIES, VOL 2, NO 1: STATE OF THE ART PRESENTATIONS, 2007, 2 (01): : 96 - +
[47] An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease
Yoshimura, Naoki
Yokoyama, Yoko
Matsuoka, Katsuyoshi
Takahashi, Hiroki
Iwakiri, Ryuichi
Yamamoto, Takayuki
Nakagawa, Tomoo
Fukuchi, Takumi
Motoya, Satoshi
Kunisaki, Reiko
Kato, Shingo
Hirai, Fumihito
Ishiguro, Yoh
Tanida, Satoshi
Hiraoka, Sakiko
Mitsuyama, Keiichi
Ishihara, Shunji
Tanaka, Shinji
Otaka, Michiro
Osada, Taro
Kagaya, Takashi
Suzuki, Yasuo
Nakase, Hiroshi
Hanai, Hiroyuki
Watanabe, Kenji
Kashiwagi, Nobuhito
Hibi, Toshifumi
BMC GASTROENTEROLOGY, 2015, 15
[48] An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease
Naoki Yoshimura
Yoko Yokoyama
Katsuyoshi Matsuoka
Hiroki Takahashi
Ryuichi Iwakiri
Takayuki Yamamoto
Tomoo Nakagawa
Takumi Fukuchi
Satoshi Motoya
Reiko Kunisaki
Shingo Kato
Fumihito Hirai
Yoh Ishiguro
Satoshi Tanida
Sakiko Hiraoka
Keiichi Mitsuyama
Shunji Ishihara
Shinji Tanaka
Michiro Otaka
Taro Osada
Takashi Kagaya
Yasuo Suzuki
Hiroshi Nakase
Hiroyuki Hanai
Kenji Watanabe
Nobuhito Kashiwagi
Toshifumi Hibi
BMC Gastroenterology, 15
[49] Report on the clinical efficacy and steroid sparing effect of granulocyte and monocyte adsorptive apheresis in patients with corticosteroid dependent ulcerative colitis
Hanai, H
Takeuchi, K
Iida, T
Tozawa, K
Tanaka, T
Saniabadi, A
Watanabe, F
Maruyama, Y
Matsushita, I
Yamada, M
Kikuchi, K
GUT, 2003, 52 : A62 - A63
[50] Evaluations of clinical efficacy and steroid sparing effect of granulocyte and monocyte adsorptive apheresis in patients with corticosteroid dependent ulcerative colitis
Hanai, H
Takeuchi, K
Iida, T
Tozawa, K
Matsushita, I
Tanaka, T
Sato, Y
Kikuti, K
Nakamura, T
Maruyama, Y
Saniabadi, A
GASTROENTEROLOGY, 2003, 124 (04) : A518 - A518

← 1 2 3 4 5 →